Key Takeaways
- UVA Health has secured two anonymous $25 million estate gifts, boosting the Manning Institute of Biotechnology’s funding to $50 million.
- The additional funding helps UVA Health exceed its $1 billion goal for the Honor the Future campaign, which concludes this month.
- A new 350,000-square-foot facility for the Manning Institute is under construction, aimed at advancing biomedical research and innovation in Virginia.
Major Support for Biotechnology at UVA
UVA Health has announced two anonymous estate gifts, each worth $25 million, aimed at bolstering the Paul and Diane Manning Institute of Biotechnology. This brings the total support for the institute to $50 million, significantly contributing to UVA’s Honor the Future campaign, which is set to end this month and has surpassed its $1 billion fundraising goal.
UVA President Jim Ryan expressed gratitude for the donations, emphasizing their potential to enhance research capabilities and develop new treatments for hard-to-treat diseases. The funds will play a vital role in realizing the Manning Institute’s mission to revolutionize healthcare in Virginia and beyond.
A new 350,000-square-foot facility, currently under construction in Fontaine Research Park, will house the institute. This state-of-the-art center is designed to foster biotechnology innovation and economic growth within the Commonwealth. The institute plans to establish a statewide clinical trials network to facilitate access to new treatments.
The Manning Institute began with a $100 million lead gift from Paul and Diane Manning, along with additional funding from the Commonwealth and UVA, totaling $350 million. Mark T. Esser, PhD, emphasized how these gifts, alongside community support, position UVA Health as a leader in transformative healthcare.
Over 52,000 donors have participated in the Honor the Future campaign, collectively raising more than $6 billion for various initiatives across UVA, significantly exceeding the $5 billion goal set at its launch in October 2019.
UVA appears committed to improving healthcare with a range of philanthropic investments, including:
– The launch of UVA Health Children’s Pediatric Neurodevelopmental and Behavioral Health clinic and expansions to neonatal and pediatric care facilities.
– Establishing specialized programs for challenging medical conditions, like Ehlers-Danlos syndrome and other hypermobility disorders.
Significant contributions have also been made to research programs, including a $30 million gift for developing Alzheimer’s treatments and a $10 million donation for blood cancer research.
Moreover, UVA Health has received $135 million for medical and nursing school scholarships, ensuring the attraction of top talent. This extends to creating endowed professorships and establishing leadership initiatives aimed at enhancing its educational mission.
Community outreach has seen support for mobile health vehicles and free health services, aligning with UVA’s mission to improve public health access. The integration of programs such as Earn While You Learn aims to strengthen the healthcare workforce across the state, further solidifying UVA Health’s commitment to both education and patient care.
The content above is a summary. For more details, see the source article.
